Key result
Visceral and intrahepatic fat drive insulin resistance and cardiovascular risk in non-obese Asian diabetes.
Answers are grounded in this paper and cite their sources.
The prevalence of non-obese type 2 diabetes in Asians is up to 50%. This review aims to summarize the role of regional fat in the development of insulin resistance and cardiovascular risk in non-obese Asian type 2 diabetes as well as the role of intra-pancreatic fat and β-cell dysfunction. The body fat content of non-obese Asian type 2 diabetic patients is not different from that of non-diabetic subjects but the proportion of intra-abdominal and intra-hepatic fat are greater. Visceral fat contributes to insulin resistance and cardiovascular risk in non-obese Asian type 2 diabetes. Intra-hepatic fat and the hypertrophic abdominal subcutaneous adipocytes are associated with insulin resistance and cardiovascular risk in non-obese, non-diabetic Asian subjects. It may be true in non-obese Asian type 2 diabetic patients. The role of intra-myocellular lipid and insulin resistance is uncertain. Intra-pancreatic fat may not be involved in β-cell dysfunction in non-obese Asian type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Chatchalit Rattarasarn (2018) conducted a review in Non-obese type 2 diabetes. Regional fat distribution (intra-abdominal, intra-hepatic, and intra-pancreatic fat) vs. Non-diabetic subjects was evaluated on Insulin resistance, cardiovascular risk factors, and β-cell dysfunction. Visceral and intra-hepatic fat contribute to insulin resistance and cardiovascular risk in non-obese Asian type 2 diabetes, whereas intra-pancreatic fat may not.
Synapse has enriched 10 related papers. Consider them for comparative context: